×
InVivo Therapeutics Holdings EBITDA 2010-2023 | NVIVQ
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
InVivo Therapeutics Holdings ebitda from 2010 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
View More
InVivo Therapeutics Holdings EBITDA 2010-2023 | NVIVQ
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
InVivo Therapeutics Holdings ebitda from 2010 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$216.5B
Boston Scientific (BSX)
$153.5B
Stryker (SYK)
$147.8B
EssilorLuxottica (ESLOY)
$131.6B
Medtronic (MDT)
$115B
Lonza Group Ag (LZAGY)
$49.2B
Haleon (HLN)
$42.8B
ResMed (RMD)
$38.3B
GE HealthCare Technologies (GEHC)
$34B
Agilent Technologies (A)
$31.8B
Terumo (TRUMY)
$24.2B
Koninklijke Philips (PHG)
$23.6B
Insulet (PODD)
$19.8B
Zimmer Biomet Holdings (ZBH)
$18.3B
Baxter (BAX)
$14B
Smith & Nephew SNATS (SNN)
$13.3B
Sunny Optical Technology (SNPTF)
$10.4B
Demant (WILYY)
$8.6B
Bio-Rad Laboratories (BIO)
$6.6B
Lantheus Holdings (LNTH)
$5B
Prestige Consumer Healthcare (PBH)
$3.7B
Perrigo (PRGO)
$3.7B
Haemonetics (HAE)
$3.5B
Shandong Weigao Medical Polymer (SHWGF)
$3.5B
Envista Holdings (NVST)
$3.3B
ICU Medical (ICUI)
$3B
LeMaitre Vascular (LMAT)
$1.8B
QuidelOrtho (QDEL)
$1.7B
AtriCure (ATRC)
$1.4B
Acuren (TIC)
$1.4B